Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > O'Leary really gave you guys a tearing.

<< Previous

Bullboard Posts

Next >>

Post by THEPUMPPROPHETon Dec 15, 2020 4:59pm

549 Views

Post# 32111811

O'Leary really gave you guys a tearing.

Wow. 2 raises?

Management must really care about all their new retail MANIC investors.

The SHROOM BOOM is OVER (for now).

The outstanding shares on this is INSANE.

I'm not sure why $4.40 would be the price -- with the warrants - I'd guess in the low 3s.

If your friend told you to buy this pumped garbage I'd call them not a friend.

Gooooood Luckkkkkk.

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale